LISA MCKNIGHT: Open Payments
NPI 1902458698 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,220 in 62 payments from 11 companies in 2025. Trend: 2023 $342 · 2024 $846 · 2025 $1,220
Food & beverage: $1,220
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $314 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $174 |
| Vanda Pharmaceuticals Inc. | 9 | $156 |
| Janssen Pharmaceuticals, Inc | 7 | $141 |
| Otsuka America Pharmaceutical, Inc. | 9 | $139 |
| Supernus Pharmaceuticals, Inc. | 2 | $63 |
| Braeburn Inc. | 2 | $58 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Indivior Inc. | 2 | $48 |
| Alkermes, Inc. | 2 | $45 |
Products named: VRAYLAR, CAPLYTA, INVEGA SUSTENNA, FANAPT, REXULTI, Qelbree, BRIXADI, ABILIFY ASIMTUFII.
Industry payments across AR — which companies pay providers there.
